Clinical Trial Update: Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating intravitreal bevacizumab and triamcinolone for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Diabetic Macular Edema | NA | Status: COMPLETED